ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
16 Dec 2018 07:46

Last Week in Event SPACE: ANTA, Japan Display, Pioneer, Naspers, Huatai, Red Hat

 Last Week in Event SPACE ... The reward/risk is pretty decent on the Anta Sports Products (2020 HK) /Amer Sports Oyj (AMEAS FH) trade. A rumoured...

Logo
671 Views
Share
bearishCelltrion Inc
13 Dec 2018 10:06

Celltrion / Celltrion Healthcare Pair Trade: Ratio Should Move in Favor of Healthcare

I initiated a pair trade (short Celltrion / long Healthcare) on Oct 22. Yield peaked at 16.66% on Nov 22. It now stays at 8.75%. The ongoing FSS...

Logo
697 Views
Share
10 Dec 2018 12:11

Smartkarma’s Week That Was in JP/​​​​​KR: Softbank, Nissan, & A Star Is Born in 2018 Rewind to 1937

The year is winding down and there are only three weeks left in 2018. The sentiment on the global stock markets has been turning down rapidly in...

Logo
497 Views
Share
02 Dec 2018 21:29

The Smartkarma Week That Was in JP/KR: Nissan, J-Retail, Tesla/Panny, SK Rights, Biosimilars, Trade

This past week featured ~160 insights across the Smartkarma platform, with 35+ of them dealing with Japan, South Korea, and semiconductors/memory...

Logo
1.1k Views
Share
bearishCelltrion Inc
28 Nov 2018 00:29

Biosimilar Battlefield Update: It's Getting Uglier

A confluence of negative news is causing sharp declines (or trading suspensions) in the share prices of Samsung Biologics Co., (207940...

Share
x